OCT-A monitoring of the efficacy of neuroprotective therapy for glaucomatous optic neuropathy

<p> <b>N.G.&nbsp;Glazko<sup>1,2</sup>, A.E.&nbsp;Egorov<sup>1,2</sup></b><br> </p> <p> <b><sup>1</sup>Hospital for Disabled Veterans No. 2, Moscow, Russian Federation</b> </p> <p> <b><...

Full description

Saved in:
Bibliographic Details
Main Authors: N.G. Glazko, A.E. Egorov
Format: Article
Language:Russian
Published: Prime-Media 2020-03-01
Series:РМЖ "Клиническая офтальмология"
Online Access:http://clinopht.com/upload/iblock/85f/85fdf4a810136d3263f1aba7e2a4526b.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841526867233865728
author N.G. Glazko
A.E. Egorov
author_facet N.G. Glazko
A.E. Egorov
author_sort N.G. Glazko
collection DOAJ
description <p> <b>N.G.&nbsp;Glazko<sup>1,2</sup>, A.E.&nbsp;Egorov<sup>1,2</sup></b><br> </p> <p> <b><sup>1</sup>Hospital for Disabled Veterans No. 2, Moscow, Russian Federation</b> </p> <p> <b><sup>2</sup>Pirogov Russian National Research Medical University, Moscow, Russian Federation</b> </p> <p> <b>Abstract</b> </p> <p> <i><b>Aim</b>: to describe morphological functional changes in patients with primary open-angle glaucoma (POAG) with good vision and controlled intraocular pressure (IOP) after trophic modified laser coagulation.</i> </p> <p> <i><b>Patients and Methods: </b>45 patients (78 eyes) aged 45–80 years with moderate and advanced POAG lasting at least one year were enrolled in the study. All patients underwent general examination (complaints and history taking) and ocular examination (visual acuity, IOP, slit lamp exam, eye fundus exam, and optical coherence tomography angiography (OCT-A) to assess foveal avascular zone (FAZ)). In addition, all patients were invited to complete a questionnaire to measure subjective perception of their vision. The examinations were performed before the treatment, the next day after trophic modified laser coagulation, the next day after administering bovine retinal polypeptides, and 7 days after starting treatment. Trophic modified laser coagulation included two steps, i.e., creation of areas of increased blood-ocular barrier permeability and administration of bovine retinal polypeptides into these areas.</i> </p> <p> <i><b>Results</b>: in patients with controlled POAG and good vision, positive changes in FAZ parameters (as demonstrated by OCT-A) as well as subjective improvement of vision (as demonstrated by completing questionnaire before and after the treatment) were revealed after trophic modified laser coagulation.</i> </p> <p> <i><b>Conclusions</b>: our findings demonstrate the efficacy of neuroretinoprotection for glaucomatous optic neuropathy due to the improved microcirculation and activation of foveal blood flow.</i> </p> <p> <i><b>Keywords</b>: optical coherence tomography angiography, primary open-angle glaucoma, glaucomatous optic neuropathy, neuroretinoprotection, trophic modified laser coagulation, bovine retinal polypeptides.</i> </p> <p> <i><b>For citation: </b>Glazko N.G., Egorov A.E. OCT-A monitoring of the efficacy of neuroprotective therapy for glaucomatous optic neuropathy. Russian Journal of Clinical Ophthalmology. 2020;20(1):–7. DOI: 10.32364/2311-7729-2020-20-1-2-7.</i> </p> <i><br> </i><br>
format Article
id doaj-art-3647a5b9524247cb9d77019e90acd157
institution Kabale University
issn 2311-7729
2619-1571
language Russian
publishDate 2020-03-01
publisher Prime-Media
record_format Article
series РМЖ "Клиническая офтальмология"
spelling doaj-art-3647a5b9524247cb9d77019e90acd1572025-01-16T09:39:38ZrusPrime-MediaРМЖ "Клиническая офтальмология"2311-77292619-15712020-03-0120131007OCT-A monitoring of the efficacy of neuroprotective therapy for glaucomatous optic neuropathyN.G. Glazko0A.E. Egorov1Russian Journal of Clinical Ophthalmology, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399Russian Journal of Clinical Ophthalmology, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399<p> <b>N.G.&nbsp;Glazko<sup>1,2</sup>, A.E.&nbsp;Egorov<sup>1,2</sup></b><br> </p> <p> <b><sup>1</sup>Hospital for Disabled Veterans No. 2, Moscow, Russian Federation</b> </p> <p> <b><sup>2</sup>Pirogov Russian National Research Medical University, Moscow, Russian Federation</b> </p> <p> <b>Abstract</b> </p> <p> <i><b>Aim</b>: to describe morphological functional changes in patients with primary open-angle glaucoma (POAG) with good vision and controlled intraocular pressure (IOP) after trophic modified laser coagulation.</i> </p> <p> <i><b>Patients and Methods: </b>45 patients (78 eyes) aged 45–80 years with moderate and advanced POAG lasting at least one year were enrolled in the study. All patients underwent general examination (complaints and history taking) and ocular examination (visual acuity, IOP, slit lamp exam, eye fundus exam, and optical coherence tomography angiography (OCT-A) to assess foveal avascular zone (FAZ)). In addition, all patients were invited to complete a questionnaire to measure subjective perception of their vision. The examinations were performed before the treatment, the next day after trophic modified laser coagulation, the next day after administering bovine retinal polypeptides, and 7 days after starting treatment. Trophic modified laser coagulation included two steps, i.e., creation of areas of increased blood-ocular barrier permeability and administration of bovine retinal polypeptides into these areas.</i> </p> <p> <i><b>Results</b>: in patients with controlled POAG and good vision, positive changes in FAZ parameters (as demonstrated by OCT-A) as well as subjective improvement of vision (as demonstrated by completing questionnaire before and after the treatment) were revealed after trophic modified laser coagulation.</i> </p> <p> <i><b>Conclusions</b>: our findings demonstrate the efficacy of neuroretinoprotection for glaucomatous optic neuropathy due to the improved microcirculation and activation of foveal blood flow.</i> </p> <p> <i><b>Keywords</b>: optical coherence tomography angiography, primary open-angle glaucoma, glaucomatous optic neuropathy, neuroretinoprotection, trophic modified laser coagulation, bovine retinal polypeptides.</i> </p> <p> <i><b>For citation: </b>Glazko N.G., Egorov A.E. OCT-A monitoring of the efficacy of neuroprotective therapy for glaucomatous optic neuropathy. Russian Journal of Clinical Ophthalmology. 2020;20(1):–7. DOI: 10.32364/2311-7729-2020-20-1-2-7.</i> </p> <i><br> </i><br>http://clinopht.com/upload/iblock/85f/85fdf4a810136d3263f1aba7e2a4526b.pdf
spellingShingle N.G. Glazko
A.E. Egorov
OCT-A monitoring of the efficacy of neuroprotective therapy for glaucomatous optic neuropathy
РМЖ "Клиническая офтальмология"
title OCT-A monitoring of the efficacy of neuroprotective therapy for glaucomatous optic neuropathy
title_full OCT-A monitoring of the efficacy of neuroprotective therapy for glaucomatous optic neuropathy
title_fullStr OCT-A monitoring of the efficacy of neuroprotective therapy for glaucomatous optic neuropathy
title_full_unstemmed OCT-A monitoring of the efficacy of neuroprotective therapy for glaucomatous optic neuropathy
title_short OCT-A monitoring of the efficacy of neuroprotective therapy for glaucomatous optic neuropathy
title_sort oct a monitoring of the efficacy of neuroprotective therapy for glaucomatous optic neuropathy
url http://clinopht.com/upload/iblock/85f/85fdf4a810136d3263f1aba7e2a4526b.pdf
work_keys_str_mv AT ngglazko octamonitoringoftheefficacyofneuroprotectivetherapyforglaucomatousopticneuropathy
AT aeegorov octamonitoringoftheefficacyofneuroprotectivetherapyforglaucomatousopticneuropathy